Articles tagged with: Viruses

Repurposing viruses to tackle pancreatic cancer drug resistance

Posted in Publications Published by Marianne Baker 15 April 2016

Repurposing viruses to tackle pancreatic cancer drug resistance

A new paper in the journal Oncotarget, led by Dr Gunnel Hallden, shows that viruses can be modified to force cancer cells to die, instead of evading apoptosis.

This also means they work better with existing anti-cancer drugs to destroy pancreatic tumours, a promising beginning to exploring more combination therapies to tackle the problem of drug resistance in pancreatic cancer...

Funding secured to revolutionise personalised prostate cancer treatments

Posted in Grants & Awards Published by Marianne Baker 23 November 2015

3D tumour model to test anti-cancer viruses & drugs

Funding secured to revolutionise personalised prostate cancer treatments

Barts Charity have funded a new project led by Dr Gunnel Halldén in our Centre for Molecular Oncology. This work aims to develop a method to test new combinations of cancer treatments on prostate cancer.

Ultimately they hope to use the test for individual patients, to provide personalised therapies...

Tackling ovarian cancer on two fronts

Posted in Grants & Awards Published by Marianne Baker 28 September 2015

Armed with viruses and the immune system

Tackling ovarian cancer on two fronts

Dr Michelle Lockley in our Centre for Molecular Oncology now has a Cancer Research UK Clinician Scientist Fellowship to continue working on oncolytic viruses for ovarian cancer.

High grade serous cancer (HGSC) is the most common subtype of ovarian cancer. Chemotherapy is usually successful at first, but > 70% of patients develop resistance...

Making anti-cancer viruses safer for ovarian cancer patients

Posted in Publications Published by Marianne Baker 24 June 2015

Making anti-cancer viruses safer for ovarian cancer patients

Dr Michelle Lockley's group has published a new study in Cancer Research showing exciting progress in the use of viruses to treat ovarian cancer.

They've found a way to potentially reduce inflammation by targeting an integrin on macrophage cells, which oncolytic viruses can bind to...

MRC grant funding success for BCI researchers

Posted in Grants & Awards Published by Marianne Baker 16 March 2015

MRC grant funding success for BCI researchers

Two new grants have been awarded to BCI researchers by the Medical Research Council (MRC).

Prof Hemant Kocher will now be able to run a Phase I trial for a new pancreatic cancer treatment, and Dr Yaohe Wang will be testing a modified cancer-killing (oncolytic) virus...

Trial of HPV vaccine completed: more effective cancer prevention

Posted in In the Press, Publications Published by Marianne Baker 19 February 2015

Trial of HPV vaccine completed: more effective cancer prevention

A new HPV (human papilloma virus) vaccine that protects against 9 types of the virus – 7 of which cause most cases of cervical cancer – has now been fully tested in a trial co-organised by Professor Jack Cuzick in the Barts CR-UK Centre.

The new vaccine offers significantly greater protection than the current vaccine, which protects against only two cancer-causing types of HPV...

Arming Vaccinia virus to attack pancreatic cancer and prevent its return

Posted in In the Press, Publications Published by Marianne Baker 13 January 2015

Arming Vaccinia virus to attack pancreatic cancer and prevent its return

Yaohe Wang's team in the Centre for Molecular Oncology has been working on a new combination of two different approaches: virotherapy and immunotherapy, which is showing “great promise” as a treatment for pancreatic cancer.

A new Vaccinia virus study was led by post-doc Dr Louisa Chard and published in late 2014...

BCI’s Dr Wang working on revolutionary ‘viro-immunotherapy’ for breast cancer

Posted in Grants & Awards Published by Marianne Baker 28 October 2014

BCI’s Dr Wang working on revolutionary ‘viro-immunotherapy’ for breast cancer

Thanks to a grant of approximately £200,000 from the research charity Breast Cancer Campaign, Dr Yaohe Wang is leading work on an innovative new treatment using modified viruses to kill breast cancer cells.

The research could lead to a promising ‘viro-immunotherapy’ for patients with triple-negative breast cancer...

BCI at the 8th International Conference on Oncolytic Virus Therapeutics

Posted in Conferences, BCI on the Road Published by Marianne Baker 10 April 2014

BCI at the 8th International Conference on Oncolytic Virus Therapeutics

From the 10th-13th of April, several BCI researchers made their way over to Oxford for the 8th International Conference on Viral Therapeutics.

Viral therapies for cancer have traditionally attracted less attention than now-standard chemotherapies, radiotherapy and newer targeted drug therapies...

BCI Scientists Receive Over £500,000 For Pancreatic Cancer Research

Posted in Grants & Awards Published by Katherine Yuk 13 March 2013

BCI Scientists Receive Over £500,000 For Pancreatic Cancer Research

Scientists from Barts Cancer Institute have received grants totalling £540,000 from the Pancreatic Cancer Research Fund (PCRF) to carry out ground-breaking research to improve the prognosis of the disease...

[12  >>  
This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.